Open-Label Certolizumab Pegol Is Effective In Patients Who Withdrew From Double-Blind Treatment Due To Non-Response

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Keystone, E; Van der Heijde, D; Smolen, J; Weinblatt, M; Kvien, T; Strand, V; Ansari, Z; Goel, N; Combe, B

Published Date

  • June 1, 2010

Published In

Volume / Issue

  • 37 / 6

Start / End Page

  • 1333 - 1333

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0315-162X

Conference Name

  • 65th Annual Meeting of the Canadian-Rheumatology-Association

Conference Location

  • Quebec, CANADA

Conference Start Date

  • February 3, 2010

Conference End Date

  • February 6, 2010